Спайдер незначительно понижается перед открытием торгов на NYSE.
Европейские индексы на положительной территории.
SPY (внутридневной график) боковое движение на премаркете. Сопротивление: 170.00 Поддержка: 169.40
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: KMX +5.5%, LEN +1.3%.
M&A news: JNY +7.8% (reports suggesting co may be acquired for $17-18 per share), AMAT +6.4% (co and Tokyo Electron (TOELY) to merge; creating a new company as a merger of equals with combined market capitalization of ~$29 bln).
Other news: GWAY +18.3% (co and Vitera Healthcare Solutions to combine), INO +7.9% (announces publication of a peer-reviewed paper demonstrating the success of its new DNA plasmid technology), OCN +4.4% (announces credit facility amendment and repurchase from WL Ross & Co), BNNY +3.1% (to replace CBST in the S&P SmallCap 600), NOV +2.5% (announces plan to pursue spin-off of distribution business into separate publicly traded company), MCP +2.1% (China will most likely increase its purchase of rare earth reserves next month, according to reports), SQNM +1.8% (announced review of strategic alternatives for its Genetic Analysis business segment), TI +1.7% (Telefonica (TEF) paid out a capital increase in Telco), ELX +1.4% (Elliot disclosed 6.4% activist stake in amended 13D filing), IGT +0.9% (and Caesars Entertainment ink video poker deal to supply 7,000 AVP video poker terminals).
Analyst comments: TOT +2.2% (upgraded to Equal Weight from Underweight at Barclays), CBEY +2.2% (upgraded to Outperform from Mkt Perform at Raymond James), FB +2.1% upgraded to Buy from Neutral at Citigroup), SD +2.1% (assumed with a Neutral at Goldman), MCHP +1.2% (upgraded to Buy from Neutral at Goldman), AAPL +0.6% (upgraded to Positive from Neutral at Susquehanna)
Gapping down:
In reaction to disappointing earnings/guidance: RHT -10.6%.
Other news: ETRM -8.3% (on track for approval decision in 1H14 following formal response to premarket approval application from FDA), ABR -5.2% (announced it has commenced a public offering of 6 mln shares of common stock), EOX -2.8% (receivedcommitment from White Deer to acquire common stock; announced public offering of 15 mln shares of common stock) NVAX -1.6% (prices Public Offering of Common Stock at $3.14/share), POT -1.6% (potentially related to CIC Chinese fund takes 12% stake in Uralkali), HTZ -1.4% HTZ -1.4% (CFO Elyse Douglas has stepped down), P -1.2% (cont downward momentum), MOS -1.2% (potentially related to news similar to POT)
Analyst comments: FFIV -2.2% (downgraded to Neutral from Buy at Goldman), WPX -1.6% (initiated with a Sell at Goldman).
Интересные новостные акции NYSEи NASDAQ:
LEN – лонг выше максимумов премаркета
FB – шорт ниже 48.00, лонг выше максимума премаркета
Спайдер понижается перед открытием торгов на NYSE.
Европейские индексы на отрицательной территории.
SPY (внутридневной график) снижение на премаркете. Сопротивление: 170.60 Поддержка: 170.00
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: AAPL +3.3% (announces it has sold 9 mln new iPhone 5s and iPhone 5c models), .
M&A news: YONG +4% (enters into definitive merger agreement, shares will be converted into the right to receive $6.69 in cash without interest), .
Other news: VGZ +10.4% (provides strategic update), MXC +5.4% (announces additional development of properties), GIVN +5% (receives clearance for the third generation PillCam SB System in Japan), SKH +3.2% (announces initial HUD loan funding), DRYS +2.6% (cont volatility), TTWO +2.3% (reports of strong GTA 5 sales over weekend), TSEM +1.8% (co and DMB Technology announced volume production and shipping results), SWIR +1.8% (still checking), CWH +1.5% (announces restructuring of management agreement with RMR and significant governance enhancements), OMC +1.2% (still checking), GE +0.9% (co and Sonelgaz affiliate, SPE, sign contracts valued at $2.7 bln to help power Algeria), LNG +0.8% (announces filing of Registration Statement for Cheniere Energy Partners LP IPO).
Analyst comments: MXIM +2.1% (upgraded to Buy from Neutral at Goldman; added to Conviction Buy List), DDD +1.4% (initiated with a Buy at BofA/Merrill), SPLK +1.3% (initiated with a Neutral at Goldman- light vol), WAG +1.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
Gapping down:
In reaction to disappointing earnings/guidance: ACTS -4.6%.
M&A news: OPAY -1.5% ( to be acquired by ACI Worldwide (ACIW) for $8.35 per share in cash).
Select financial related names showing weakness: BCS -1.9%, GS -1%, LYG -0.8%, JPM -0.8%, MS -0.7%.
Other news: FSM -6.7% (completes 1,800 tpd mill expansion on-time and on-budget at the San Jose Mine, Mexico), C -2.4% (may have large drop in trading revenue in Q3, according to reports), P -1.8% (reports Apple is paying $0.01 more per song in royalties to record cos vs Pandora, cautious blog article making rounds), JCP -1.7% (in talks to raise more capital, according to reports), KNDI -1.5% (files for 1,255,462 share offering of common stock issuable upon exercise of warrants by selling shareholders), NSC -0.7% (announces retirement of CFO John Rathbone, names Marta Stewart CFO).
Analyst comments: BBRY -6.4% (downgraded to Hold from Buy at Jefferies, also downgraded to Underperform from Sector Perform at RBC Capital Mkts), RNA -5.5% (downgraded to Neutral from Buy at Citigroup - timing unclear), CTRX -2.7% (downgraded to Equal-Weight from Overweight at Morgan Stanley), KORS -1.3% (downgraded to Hold from Buy at Jefferies), NGG -1% (downgraded to Neutral from Buy at UBS), SEE -0.7% (downgraded to Equal Weight from Overweight at Barclays).
Интересные новостные акции NYSEи NASDAQ:
SCTY – лонг выше 38.00
C – шорт ниже минимума премаркета, при закреплении выше 50.00 – лонг.
SPY (внутридневной график) снижение движение на премаркете. Сопротивление: 172.20 Поддержка: 171.50
ПремаркетNYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: TIBX +7.8%, NQ +4.3%, CTAS +3%.
M&A news: VRNM +58.6% (enters agreement to be acquired by BASF (BASFY) for $4.00 per share in cash).
Other news: CYCC +35.3% (sapacitabine reported to have anti-tumor activity against ovarian cancer), JKS +6.3% (prices 3.8 mln ADS follow on offering at $16.25), GT +4.4% (reconfirmed its outlook for 2013 segment operating income; Reinstates cash dividend on common stock, announces share repurchase program), NAVB +4.2% (independent investigators reported Lymphoseek results in JAMA Otolaryngology Head and Neck Surgery), TSPT +2.7% (Roumell Asset Management issued letter to Board: 'Retrophin offer of $4 per share is woefully inadequate'), JCP +2.1% (Vornado (VNO) selling 13.4 mln share stake), KIOR +1.7% (provides operational update on Columbus Facility: as of August 31, 2013), AAPL +1.6% (launches iPhone 5s and 5c today), HIMX +1.6% (still checking), SSTK +1.4% (prices 4.6 mln share follow on offering of common stock at $60.00 per share; shares offered by co and selling shareholders), LGF +1.3% (CFO James Keegan retiring, will be succeeded as CFO by former Viacom CFO James Barge), KNDI +1.2% (cont strength).
Analyst comments: SUNE +2.5% (upgraded to Outperform from Sector Perform at RBC Capital Markets), URBN +2.3% (upgraded to Buy from Hold at Canaccord Genuity), PIR +1.7% (upgraded to Outperform from Neutral at Credit Suisse), NTAP +-1.6% (downgraded to Underperform from Mkt Perform at William Blair), MET +1.2% (added to Conviction Buy List at Goldman), FLML +0.8% (initiated with Mkt Outperform at JMP Securities)
Gapping down:
In reaction to disappointing earnings/guidance: AKS -12.2%, TWI -5.6%, DRI -4.4%, FOXF -3.4%.
Select Indian related names showing weakness after RBI rate hike: TTM -1.9%, IBN -3.4%, HDB -1.9%.
Select metals/mining stocks trading lower: GFI -3.2%, AU -2.6%, GOLD -2.2%, SLV -2.2%, SLW -1.7%, ABX -1.7%, GG -1.7%, X -1.3% (also AKS and MT peer), GLD -1.2%.
Select shipping related names sinking early: BALT -9.8% (announced common stock offering), NMM -5.9% (announced public offering of 5 mln common units), FRO -5.8%.
Other news: RNA -77.6% (co and and GSK announce primary endpoint not met in Phase 3 study of Drisapersen), SRPT -6.5% (related to GSK/RNA news), KAR -2.7% (announced secondary offering of 12 mln shares of common stock by existing stockholder KAR Holdings II, LLC), KAR -2.7% (prices 12 mln share offering (selling stockholder, KAR Holdings II) at $27.35/share), AFH -2.5% (filed for ~1.26 mln share common stock offering by selling shareholders), AEM -1.6% (announced development project update - La India commissioning underway and mining and processing has restarted at Goldex), NEE -1.6% (to sell $500 mln of equity units), NEE -1.6% (agreed to sell $500 mln of equity units to Citigroup (C), Morgan Stanley (MS), and Credit Suisse (CS)), RBS -1.1% (plans to sell Direct Line for GBP 630 mln, according to reports), NLY -0.7% (announced Q3 dividend of $0.35 per share vs $0.40 in prior quarter).
Analyst comments: MT -1.9% (downgraded to Sector Perform from Outperform at RBC Capital Markets), BRKR -1.9% (downgraded to Market Perform from Outperform at Wells Fargo), SWI -1.8% (downgraded to Sell from Neutral at Goldman), NTAP -1.6% (downgraded to Underperform from Mkt Perform at William Blair), CLX -1% (downgraded to Underperform from Neutral at Credit Suisse), SIAL -1% (downgraded to Neutral from Outperform at Robert W. Baird), AIZ -0.9% (downgraded to Neutral from Buy at Goldman), NLSN -0.8% (downgraded to Mkt Perform from Outperform at Bernstein, initiated with a Neutral at Goldman).
Спайдер повышается перед открытием торгов на NYSE.
Европейские индексы на положительной территории.
SPY (внутридневной график) рост движение на премаркете. Сопротивление: 174.00 Поддержка: 173.00
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: RAD +13.2%.
M&A news: MCBI +24.4% (co and East West Bancorp (EWBC) enter into definitive agreement for merger), BMRN +8.9% (Bloomberg discusses speculation that Roche (RHHBY) may secure financing for BMRN bid, according to reports).
Other news: ACUR +12.6% (provided update on NEXAFED launch: now being sold in over 2,600 pharmacies nationwide), A +11.3% (to separate into two public companies; spinoff is not anticipated to impact co's guidance for fiscal year 2013), ONVO +10.4% ( diclosed it entered into an agreement with Hoffmann La Roche exploring the use of 3D liver tissue in toxicology), TSPT +10% (Retrophin proposed acquisition of co for $4 per share), KNDI +7.5% (confirms Chinese Government issued 2013-2015 subsidy policy for new energy vehicles), TTWO +4.7% (Grand Theft Auto V sales may have hit ~ $1 bln worldwide during first day of launch, according to reports), ISIS +3.7% (reports follow-up data from iSIS-SMN Rx Phase 1 study in children with spinal muscular atrophy), HIMX +2.8% (cont strength), TTM +2.6% (strong move in the Sensex overnight), IBN +1.9% (stong Sensex mkt overnight), MT +1.8% (ArcelorMittal and Technip (TKPPY) signed contract for the supply of high-performance steel wires), ICUI +1.8% (reports two new clinical studies show ChemoClave System improves safety), AAPL +1.1% (WantChinaTimes discusses declining market share for AAPL in China).
Analyst comments: GTAT +7.3% (upgraded to Buy from Neutral at UBS), GRPN +3.6% ( upgraded to Buy at Stifel), TSLA +2.6% (tgt raised to $200 from $160 at Deutsche Bank), HERO +2.4% (reinstated with a Buy at Deutsche Bank), DEO +2% (upgraded to Outperform from Mkt Perform at Bernstein), DEG +1.7% (upgraded to Buy from Neutral at Nomura), TWX +1.7% (upgraded to Overweight from Equal-Weight at Morgan Stanley), AG +1.6% (upgraded to Strong Buy from Outperform at Raymond James)
Gapping down:
In reaction to disappointing earnings/guidance: PIR -7.8%, SCS -5.4%, APOG -3.4%, MLHR -2%, CLC -1.2%, CAG -1.2%.
Other news: ROYT -7.1% (announces public offering by selling unitholders of 13.5 mln units), ARR -4.3% (lowered Q4 dividend to $0.05 from $0.07 per share in prior quarter), SSNC -3.7% (filed for 7,469,799 share common stock offering by selling shareholders), FSC -3.5% (commenced public offering of 15 mln shares of common stock), SSH -3.1% (announced proposed public offering of common shares; size not disclosed), ATVI -1.4% (announced that a court ruled to halt the closing of a transaction with Vivendi), HTS -1.4% (lowered quarterly dividend 21% to $0.55 per share).
Analyst comments: DIS -1% (downgraded to Equal-Weight from Overweight at Morgan Stanley), CSCO -1% (initiated with an Underperform at Credit Suisse).
Интересные новостные акции NYSEи NASDAQ:
ABX – шорт ниже 20.00
PIR – лонг выше 22.00
CAG – лонг выше 32.00, ниже минимума премаркета смотрим акцию в шорт
ORCL – лонг выше 34.00
A – шорт ниже 52.00, выше 54.00 смотрим акцию в лонг.
Спайдер незначительно повышается перед открытием торгов на NYSE.
Европейские индексы на положительной территории.
SPY (внутридневной график) боковое движение на премаркете. Сопротивление: 171.00 Поддержка: 171.50
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: AFOP +13.4%, ADBE +5.7%, FDX +2.8%, GIS +0.6%.
M&A news: GRPN +0.8% (cquires local experience startup SideTour).
Select EU financial related names showing strength: IRE +1.9%, SAN +1.9%, HBC +1.4%, BCS +1.2%.
Other news: CIS +0% (enters into a merger agreement for a 'going private' transaction;), INVN +4.9% (still checking), DLTR +3.5% (announced $2 bln share repurchase authorization) CPRX +2.4% (still checking), WDAY +1.2% (Salesforce.com (CRM) announced plans to integrate the entire Salesforce and Workday product lines), AAPL +1.1% (releasing iOS 7 today, also Pacific Crest's increases estimates), BMRN +1% (possitive mention on Mad Money), CRZO +1% (possitive mention on Mad Money).
Analyst comments: FI +4.9% (initiated with an Overweight at Barclays, initiated with a Buy at UBS), NOK +3.5% (upgraded to Outperform from Neutral at Credit Suisse), AON +2.2% (initiated with a Buy at Guggenheim), VIPS +1.8% (upgraded to Buy from Hold at Deutsche Bank), ARUN +1.5% (initiated with an Overweight at Piper Jaffray), CL +1.2% (upgraded to Overweight from Equal Weight at Barclays), CTSH +1.1% (upgraded to Overweight from Equal Weight at Barclays).
Gapping down:
In reaction to disappointing earnings/guidance: CBRL -2.8%, AXLL -0.9%.
Other news: CBMX -6.7% (filed for $10 mln offering of Class A Units and Class B Units), FIVE -3.2% (announced secondary offering of 7.1 mln shares by selling shareholders; Executive Chairman to sell 100k shares), FLTX -2.2% (prices follow-on offering of 5,976,443 of its ordinary shares at a price to the public of $46.79/share), QIWI -1.6% (public offering of 8,197,866 ADSs by selling shareholders).
Analyst comments: VPHM -1.9% (downgraded to Neutral from Buy at BofA/Merrill), JOY -1.2% (downgraded to Neutral at Robert W. Baird ), INTU -1% (downgraded to Underweight from Equal-Weight at Morgan Stanley), PG -0.9% (downgraded to Equal Weight from Overweight at Barclays), NRG -0.8% (downgraded to Neutral from Buy at Goldman; removed from Conviction Buy list), CLX -0.7% ( downgraded to Underweight from Equal Weight at Barclays), CAT -0.6% (downgraded to Neutral at Robert W. Baird).
Other news: RPRX +31.1% (reports preliminary findings: Second Pivotal study and 6-month safety study support Androxal approvability), KYTH +30.5% (announced positive ATX-101 top line Phase 3 trial results for the reduction of submental fat), AGEN +23.7% ('positive' follow-on Phase 2 Results for Brain cancer vaccine in newly diagnosed patients;), ARO +12.1% (Hummingbird disclosed a 7.96% active stake in a 13D filing ), DFS +4.9% (reports August card metrics), BCRX +2.8% (awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease), TPLM +2.2% (expands Caliber Infrastructure System), BSX +2.2% (reports favorable six-month results from Lotus Valve System clinical trial), RMTI +1.9% (FDA acceptance of Triferic as proprietary trade name for investigational iron-delivery drug SFP), PERI +1.7% (bounce following yest weakness), TTWO +1.6% (GTA release today), SNY +1.4% (Genzyme receives European Commission approval for multiple sclerosis treatment Lemtrada).
Analyst comments: DAL +2.4% (upgraded to Overweight from Neutral at JP Morgan), LCC +2.4% (upgraded to Overweight from Neutral at JP Morgan), SOHU +2.3% (upgraded to Buy from Neutral at Goldman; added to Conviction Buy list), VOLC +2% (upgraded to Outperform from Mkt Perform at BMO Capital Markets), DDD +1.9% (initiated with an Outperform at Credit Suisse),BRCM +1.4%(upgraded to Positive from Neutral at Susquehanna), APA +1.1% (upgraded to Outperform at Oppenheimer
Gapping down:
In reaction to disappointing earnings/guidance: OUTR -16.3%, CVT -9.4%, OCLR -5.5%, WERN -4.8%, FDS -1%.
Other news: FFHL -9% ( Learns result of auction of controlling interest), JKS -4.9% (announced the offering of 3.5 mln American Depositary Shares), P -3.1% (filed for 14 mln share common stock offering, with 4 mln shares being sold by selling stockholder), LYG -3% (Britan has begun 6% stake sale has has been priced at 75-76 pence per share, according to reports citing sources), MTW -2.9% (announced the termination of its potential joint venture with Shantui Investment co), JRCC -2.8% (adjusts production in Central Appalachia in response to continued weak coal markets), CE -2.3% (increases prices on Acrylic Emulsions in Americas), MOS -2.1% (loweredQ3 price and volume guidance for Potash and Phosphates segments; sees potash volume of 1.45-1.65 mln tonnes, realized price of $330-340 per tonne) PHG -2% (plans $2 bln share buyback and has increased financial targets, according to reports), IPI -1.4% (MOS peer), POT -1.2% (MOS peer), TSLA -1.2% (California New Car Dealers Associatiom investigating TSLA's a lease finance program, according to reports, also GM plans to introduce affordable electric cars, according to reports).
Analyst comments: BGFV -2.9% (downgraded to Neutral from Overweight at Piper Jaffray), CAG -1.6% (downgraded to Neutral from Overweight at JP Morgan), K -1.3% (downgraded to Underweight from Neutral at JP Morgan), FITB -1% (downgraded to Neutral from Buy at Goldman), IACI -0.7% (downgraded to Sector Perform from Outperform at RBC Capital Markets), XONE -0.6% (initiated with a Underperform at Credit Suisse).
Спайдер повышается перед открытием торгов на NYSE.
Европейские индексы на положительной территории.
SPY (внутридневной график) рост на премаркете. Сопротивление: 171.50 Поддержка: 171.00
Премаркет NYSE/NASDAQ:
Gapping up:
M&A news: BZ +26.7% (to be acquired by Packaging Corp. of America (PKG) for $12.55 per share in cash), PKG +10.9% (acquisition is expected to be accretive to earnings immediately), SOHU +7.1% (Sohu.com, Sogou and Tencent (TCEHY) jointly announce strategic cooperation).
Select Potash related names showing strength; move attributed to speculation that Belarus issues will be resolved: CF +2%, POT +1.9%, MOS +1.7%.
Select metals/mining stocks trading higher: CLF +2.9%, MT +2.7%, X +1.7%, BHP +1.7%, RIO +1.5%.
Select solar related names showing strength ahead of this weekend's summit in China: YGE 4%, STP 3.8%, JKS 1.9%, SPWR 1.1%.
3D related names showing early strength; still searching on catalyst - all on light volume: DDD +2.4%, XONE +2.3%, SSYS +1.7%.
Other news: PSTI +8.7% ( FDA lifts clinical hold on co's Phase II intermittent Claudication study), BTH +7% (cont strength following positive blog mention on Friday), LLEN +4.1% (enters new energy business initiative in Beijing), YELP +3.3% (still checking), DAL +2.8% (cont strength from last week), MU +2.5% (sees reduced DRAM supplies, according toreports), P +1.9% (potentially Cumulus Media has agreed to an online radio deal with music service Rdio, according to reports), TSLA +1.3% (still checking, reports of co working on new hybrid battery, increasing range by 40%), GSK +1.3% (FDA grants GSK and Genmab's Arzerra (ofatumumab) Breakthrough Therapy Designation for previously untreated chronic lymphocytic leukemia), BA +1% (nearing S Korea jet deal, according to reports).
Analyst comments: HUN +2.5% (upgraded to Buy from Hold at Jefferies), MOH +2.2% (upgraded to Buy from Hold at Jefferies), WU +2.1% (upgraded to Buy from Neutral at Sterne Agee), AZN +2.1% (upgraded to Buy from Sell at Nordea), BMY +2% (upgraded to Overweight from Neutral at JP Morgan).
Gapping down:
Briefing note: With Stock Index futures ~+1% this morning, only a handful of names are gapping lower. The following represent the most notable early names.
M&A news: QIHU -6.1% (potentially related to news that Sohu, Sogou and Tencent Holdings jointly announced the establishment of a strategic cooperation, it was speculated that QIHU may purchase Sogou).
Select metals/mining stocks trading lower with Gold and Silver ETFs trading lower: SLV -1.8%, AUY -1.6%, AG -1.6%, PAAS -1.3%, SLW -1%, GLD -0.9%, GG -0.9%.
Other news: PERI -5.2% (announces agreement to combine Conduit's Client Connect business with Perion in an all-stock transaction; immediately accretive), KCAP -3% (lowers Q3 dividend to $0.25 per share from $0.28 in prior quarter), IAG -3% (its partners in the Yatela Mine in Mali to suspend mining excavation activities), NOK -1.6% (still checking; co announced release of 2 new camera phones this morning).
Интересные новостные акции NYSEи NASDAQ:
HAL – лонг выше 50.50
SOHU – ниже 68.00 – шорт, выше 69.00 смотрим акцию в лонг.
Спайдер остается без изменений перед открытием торгов на NYSE.
Европейские индексы на отрицательной территории.
SPY (внутридневной график) боковое движение на премаркете. Сопротивление: 169.75 Поддержка: 168.75
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: ULTA +14.3%, LFVN +5.9%, UNFI +4.2%, ALOG +3.2%, MBII +1.8%.
Other news: SGMO +4.6% (announced presentation of clinical data demonstrating functional control of viremia in HIV-infected subjects treated SB-728-T), SFNC +2.9% (to acquire Metropolitan National Bank), CTIC +2.8% (announces sales of Conv Pref Stock), LDK +2.6% (engages financial advisor for offshore debt obligations), SUNE +1.1% (public offering of 30 mln shares of common stock at a price of $7.25/share), EVTC +0.7% (prices 20 mln shares of common stock by affiliate of Apollo Global Mgmt and other selling shareholders at $22.50 per share ).
Analyst comments: OCLR +6.2% (upgraded to Buy from Neutral at B. Riley & Co), SWY +3.2% (upgraded to Outperform from Neutral at Credit Suisse), SFNC +2.9% (pgraded to Outperform from Mkt Perform at Raymond James, upgraded to Overweight from Equal-Weight at a boutique firm), WFT +2% (upgraded to Outperform from Neutral at Credit Suisse), INTC +1.9% (upgraded to Buy from Hold at Jefferies), LULU +1.4% (upgraded to Outperform from Neutral at Credit Suisse), AET +1.2% (pgraded to Buy from Neutral at BofA/Merrill), CMC +1.1% (upgraded to Neutral from Underperform at BofA/Merrill)
Gapping down:
In reaction to disappointing earnings/guidance: COV -2.3%.
Select metals/mining stocks trading lower: MT -1.6%, RIO -1.5%, AU -1.5%.
Select names showing early weakness following public offerings: GALE -10.1% (announced proposed public offering of common stock and warrants, size not disclosed), ARTX -8.3% (announces proposed public offering of common stock- size not disclosed), ARTX -8.3% (offering of ~3.43 mln shares of its common stock at a purchase price of $1.75/share), NSPH -5.5% (announced commencement of public offering of common stock, size not disclosed), PVR -4% (announces public offering of 5.5 mln common units), SSYS -3.7% (prices 4.5 mln shares of ordinary shares at $93.00 per share), MKTO -2.3% (prices 6 mln share of common stock follow-on offering at $35.50 per share), DRWI -2.2% (announces proposed public offering of common units), EMKR -1.9% (intends to offer 2.5 mln shares of common stock in public offering ), NXPI -1.6% (selling shareholders commence secondary offering of 25 mln shares of common stock), HAIN -1.4% (announced sale of 3,589,963 shares of common stock by selling stockholders), SN -1.4% prices 9.6 mln shares of the Company's common stock at a price of $23.00/share).
Other news: DCTH -5.4% (receives complete response letter from fda for Melbleztm kit new drug application), GFI -1.7% (S African miner unions have ended strike and have agreed to 12% pay hike, according to reports ), YHOO -1.1% (Alibaba.com IPO may delayed due to terms of Yahoo (YHOO) stake deal, according to reports), TSLA -0.9% (Elon Musk says it is 'not as crazy' in reference to shorting the stock at these levels in FBN interview; recall he made a similar statement about the co's stock valuation a few weeks ago).
Analyst comments: MPWR -2.9% (downgraded to Hold from Buy at Needham), UA -1.4% (downgraded to Neutral from Outperform at Credit Suisse ), AXLL -1.4% (downgraded to Neutral from Buy at BofA/Merrill), HMY -1.4% (downgraded to Sell from Neutral at Goldman), RIG -0.9% (downgraded to Mkt Perform from Outperform at Bernstein).
Интересные новостные акции NYSEи NASDAQ:
COV – шорт ниже 60.00, при закреплении выше – лонг.
ULTA – шорт ниже 112.00
LULU – шорт ниже 65.30, лонг при закреплении выше 60.00
Спайдер повышается перед открытием торгов на NYSE.
Европейские индексы на положительной территории.
SPY (внутридневной график) рост на премаркете. Сопротивление: 169.50 Поддержка: 169.00
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: NTWK +15.7%.
M&A news: OCLR +48.1% (II-VI announces acquisition of co's Switzerland-Based Semiconductor laser business for $115 mln; expands credit facility), STSA +9.2% (to merge with Umpqua (UMPQ); Sterling shareholders to receive 1.671 shs of UMPQ and $2.18 in cash).
Other news: P +5.2% (named Brian McAndrews Chief Executive Officer, President and Chairman) SSH +4.5% (implants first patient in C-Pulse Counter HF US Pivotal Trial), SNTA +4.5% ( announces Fast Track designation granted for ganetespib in non-small cell lung adenocarcinoma), RCL +3.7% (increases quarterly dividend to $0.25 per common share, previous $0.12 per common share), SOL +3.5% (still checking), CMO +3% (to be added to the S&P SmallCap 600), VRTX +2.4% (to be added to the S&P 500), HK +2.4% (enters into agreements to divest non-core conventional assets for ~ $302 mln), NBS +1.9% (awarded $147,765 NIH grant for treatment of skin wounds in Scleroderma patients), AVAV +1.2% (Engaged Capital sent additional letter to AVAV's Board; Engaged has withdrawn its director nomination of one candidate from this year's election), FIO +1.2% (Bloomberg last night discussed takeover speculation in FIO (speculation has been ongoing this week)), AME +1.1% (to be added to the S&P 500), QCOM +1% (announced new $5 bln stock repurchase program) YHOO +1.0% (CEO says active users have grown by 20% since she took over as CEO, according to reports), AAPL +1% (Carl Ichan stated he added to position on CNBC interview; Digitimes discusses that total tablet shipments will top PC shipment by Q4 of 2014, according to reports).
Analyst comments: ASML +2.2% (reinstated with a Buy at Goldman and added to Conviction Buy list), ZNGA +1.7% (upgraded to Equal-Weight from Underweight at Evercore), STML +1.7% ( initiated with an Outperform at Wedbush), FB +1.3% (CLSA raises tgt on FB to $60 from $42)
Gapping down:
In reaction to disappointing earnings/guidance: MW -14%, VRA -8.6%, LULU -7.4%, BRC -3.3%, OCC -2.3%, GWW -0.7%.
Other news: GLUU -6.6% (announced proposed public common stock offering), WFT -6.6% (disclosed it is selling 38.5% equity interest in Borets International for $400 mln, also downgraded to Neutral from Outperform at Macquarie, downgraded to Market Perform from Outperform at Wells Fargo, downgraded to Mkt Perform from Outperform at Raymond James), PLX -5% (announced $60 mln offering of convertible notes), CHFC -4.1% (announced $50 mln public offering of common stock), BRSS -3.8% (filed for 5 mln share common stock offering by selling stockholders), GBDC -3.2% (announced public offering of 3 mln shares of common stock) AMD -2.9% (being replaced in S&P 500), ARMH -1.8% (cont weakness), KRC -1.5% (announced public offering of 4.5 mln shares of common stock), SNY -1.3% (announced its decision to withdraw the Lixisenatide New Drug Application in the U.S), SI -1% (Josef Ackermann will resign from supervisory board of SI, according to reports).
Analyst comments: BUD -1.9% (downgraded to Reduce from Neutral at Nomura), NFLX -1.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley), CLF -1.6% (downgraded to Mkt Perform at FBR Capital ), HAL -1.1% (downgraded to Neutral from Outperform at Macquarie).
Интересные новостные акции NYSEи NASDAQ:
WFT – шорт ниже 14.60, лонг выше 15.00
STSA – шорт ниже 29.00
LINE – лонг выше максимумов премаркета
RCL – шорт ниже минимума премаркета, лонг выше 40.50
MW – лонг при закрепелении выше 34.00
KRC – лонг выше 51.00
LULU – лонг выше локального максимума премаркета, шорт ниже 64.00
VRA – шорт ниже минимума премаркета, лонг выше 18.00
Спайдер повышается перед открытием торгов на NYSE.
Европейские индексы на положительной территории.
SPY (внутридневной график) рост движение на премаркете. Сопротивление: 169.00 Поддержка: 168.20
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: FIVE +14.3%, LLEN +8.6%, TPLM +5.5%, CBK +4.2%, PANW +4.1%, .
Select EU financial related names showing strength: NBG +3.7%, ING +2.4%, DB +2%, LYG +1.6%, BCS +1.5%, .
Select India related names showing strength with Sensex +3.8% gain today: TTM +7%, INFY +4.1%, IBN +3.6%.
Other news: USU +4.7% (cont strenght from yest), RYAAY +4% (still checking), MT +2.6% (strong Ind Prod figure from China), RIO +2.4% (strong Ind Prod figure from China), RCL +2% (relief rally with Syria tensions easing).
Analyst comments: FIO +4% ( upgraded to Overweight from Neutral at Piper Jaffray), MRVL +3.4% (upgraded to Overweight from Neutral at JP Morgan), UEPS +1.6% ( upgraded to Buy from Neutral at Janney), JBL +1.5% (upgraded to Strong Buy from Buy at Needham), EXAS +1.4% (assumed with a Speculative Buy at The Benchmark Company), MYL +1.4% ( upgraded to Outperform from Mkt Perform at Bernstein ), LVS +1.3% (tgt to $72 from $66 at JPMorgan).
Other news: NBIX -25.3% (Announces Phase IIb Results Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia; 50mg dose of NBI-98854 did not meet the primary endpoint in the Phase IIb Kinect study while the 100mg dose showed a statistical and clinically significant improvement), CCXI -19.7% (eports top-line interim results for CCX140 in an ongoing Phase II trial;), NRGM -4.6% (announces public offering of 11 mln common units), RNO -4.3% ( announces public offering of 1.1 mln common units representing limited partner interests in Rhino), KW -3.9% (announces 6 mln share offering), STWD -3.6% ( announces public offering of 25 mln shares of common stock), EEQ -3.6% (commences public offering of ~ eight million of its Listed Shares), MITT -2.4% (still checking), UMBF -2.3% (announces public offering of 3.9 mln shares of its common stock), .
Analyst comments: DG -0.6% (downgraded to Equal Weight from Overweight at Barclays).
Интересные новостные акции NYSEи NASDAQ:
HDS – лонг выше 23.00, шорт ниже минимумов премаркета
Оставить комментарий
